Filing Details

Accession Number:
0001818382-24-000067
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-05-21 16:08:57
Reporting Period:
2024-05-20
Accepted Time:
2024-05-21 16:08:57
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1818382 Humacyte Inc. HUMA Biological Products, (No Disgnostic Substances) (2836) 851763759
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1877453 N. Max Wallace 2525 East North Carolina Highway 54
Durham NC 27713
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-05-20 4,015 $6.21 4,015 No 4 P Indirect Max Wallace SEP IRA
Common Stock Acquisiton 2024-05-20 3,990 $6.29 3,990 No 4 P Indirect Max N Wallace IRA
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect Max Wallace SEP IRA
No 4 P Indirect Max N Wallace IRA
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 56,550 Direct